Highlighting significant 21st century healthcare trends, life science thematic funds focus on potential medical breakthroughs by tracking a basket of biotechnology stocks and pharmaceutical stocks
Medical advances often make the headlines and generate considerable investor interest in the biopharmaceutical segment. Funds are undoubtedly the best option for investors interested in genetics, molecular diagnostics and stem cell advances because major uncertainty of R&D outcome at individual labs and clinical testing will be balanced by careful fund diversification
Significant performance differentials between the funds are related in part to stock selection in actively managed funds, but also to the relative weight allocated to major pharmaceutical companies (less likely to outperform but also less risky)
Although this may be counter-intuitive, our theme confronts potential biotechnology advances with some popular long term health and lifestyle choices - such as medical and recreational cannabis consumption or the special needs of aging demographics. The entire suite of popular cannabis ETFs is included in a special theme